Hound Partners, LLC Vapotherm Inc Transaction History

Hound Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.52 - $14.42 $1.51 Million - $8.64 Million	-599,100 Reduced 42.1%	824,098 $2.09 Million
Q1 2022 May 13, 2022	BUY	$12.69 - $20.72 $256,477 - $418,771	20,211 Added 1.44%	1,423,198 $19.8 Million
Q4 2021 Feb 14, 2022	BUY	$19.7 - $23.71 $731,559 - $880,470	37,135 Added 2.72%	1,402,987 $29.1 Million
Q3 2021 Nov 15, 2021	SELL	$21.32 - $29.36 $13.9 Million - $19.2 Million	-653,962 Reduced 32.38%	1,365,852 $30.4 Million
Q2 2021 Aug 16, 2021	SELL	$17.01 - $24.14 $1.73 Million - $2.46 Million	-101,721 Reduced 4.79%	2,019,814 $47.7 Million
Q1 2021 May 17, 2021	BUY	$21.8 - $36.52 $7.07 Million - $11.9 Million	324,526 Added 18.06%	2,121,535 $51 Million
Q4 2020 Feb 16, 2021	BUY	$23.44 - $31.85 $42.1 Million - $57.2 Million	1,797,009 New	1,797,009 $48.3 Million

1.29M

Ticker VAPO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,697,200
Market Cap $57.9M
Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow...

Get notified when there are updates to the investment portfolio of Hound Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Hound Partners, LLC with notifications on news.